Volume 34, Issue 12, December 2019

A newly established clinical registry of minimal change disease and focal and segmental glomerulosclerosis in Germany

• Extract
• View article

Fibroblast growth factor 23 in chronic kidney disease: what is its role in cardiovascular disease?

• Extract
• View article

Will the results of the Proactive IV Iron Therapy in Haemodialysis Patients trial impact the anaemia guidelines?

• Extract
• View article

Recent developments in endovascular interventions to sustain vascular access patency in haemodialysis patients

• Abstract
• View article

Glomerular filtration rate: when to measure and in which patients?

• Abstract
• View article

Emerging evidence of an effect of salt on innate and adaptive immunity

• Abstract
• View article

Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney

• Extract
• View article

Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression

• Abstract
• View article
• Supplementary data

Excessive salt intake increases peritoneal solute transport rate via local tonicity-responsive enhancer binding protein in subtotal nephrectomized mice

• Abstract
• View article
• Supplementary data

Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction

• Abstract
• View article
• Supplementary data

Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease

• Abstract
• View article
• Supplementary data

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans

• Abstract
• View article
• Supplementary data

First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease

• Abstract
• View article
• Supplementary data

Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

• Abstract
• View article
• Supplementary data

Is high-volume post-dilution haemodiafiltration associated with risk of fluid volume imbalance? A national multicentre cross-sectional cohort study

• Abstract
• View article
• Supplementary data

Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality

• Abstract
• View article
• Supplementary data

Guideline attainment and morbidity/mortality rates in a large cohort of European haemodialysis patients (EURODOPPS)

• Abstract
• View article
• Supplementary data

Red blood cell distribution width and mortality and hospitalizations in peritoneal dialysis patients

• Abstract
• View article
• Supplementary data

Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study

• Abstract
• View article
• Supplementary data

External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population

• Abstract
• View article

Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study

• Abstract
• View article
• Supplementary data

Regulatory/inflammatory cellular response discrimination in operational tolerance

• Abstract
• View article
• Supplementary data

APOL1 gene variants and kidney disease in whites: the cardiovascular health study

• Extract
• View article
• Supplementary data